# Pioglitazone in Hepatitis C

> **NCT00189163** · PHASE4 · COMPLETED · sponsor: **University of Michigan** · enrollment: 40 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT00189163
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-12
- **Final completion:** —
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189163, "Pioglitazone in Hepatitis C". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00189163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*